Pharmacy operations, particularly clinical reviews of injectables and similar high-cost drugs, create operational and cost challenges for health plans. Health plans are inundated with prescriptions for costly medications that require an expert clinical review of the patient’s history prior to authorization. These preauthorizations are typically performed by clinicians, which can drain high-cost resources. These challenges and the time-consuming review add significant costs and create tension between the health plan, the provider, and the member.